Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolic acid pharmacokinetics and toxicity study in Chinese heart transplant recipients
ChiCTR2000030903Phase 4Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolic acid in heart transplantation (3 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Plasma concentration of mycophenolic acid. Started Dec 2019; status: recruiting.
02
Drugs
mycophenolic acid
03
Conditions
heart transplantation
Beyond the preview
Go deeper on ChiCTR2000030903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030903.